Aleph Farms Limited entered into an Asset Purchase Agreement to acquire manufacturing facility in Israel from Vascular Biogenics Ltd. for $7.1 million.

Aleph Farms Limited entered into an Asset Purchase Agreement to acquire manufacturing facility in Israel from Vascular Biogenics Ltd. (NasdaqGM:VBLT) for $7.1 million on February 15, 2023. The transaction is expected to close on or about March 9, 2023.